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92Objectives:We hypothesized that a large number of patients with diabetic retinopathy who could benefit greatly
from early coronary artery bypass grafting would not be identified.
Methods: Patients with diabetic retinopathy receiving ophthalmologic care as outpatients in our hospital in whom
coronary artery disease was not previously suspected were referred randomly to the diabetic retinocoronary clinic
and were asked to participate in diagnostic tests, including an exercise treadmill test and exercise thallium scin-
tigraphy or coronary computed tomography. Patients who had type 1 diabetes mellitus, required hemodialysis, or
both were excluded from this study. A definitive diagnosis of coronary artery disease was confirmed by means of
coronary angiography.
Results:Of 214 patients with diabetic retinopathy, 55 (25.7%) were confirmed as having significant stenotic cor-
onary artery disease. Patients with angiographically confirmed coronary disease were older than those with
negative results on diagnostic tests (62.2  9.8 vs 57.9  10.3 years, P ¼ .01). Fifteen had 1-vessel disease,
17 had 2-vessel disease, 14 had 3-vessel disease, 1 had left main trunk plus 1-vessel disease, 2 had left main trunk
plus 2-vessel disease, and 5 had left main trunk plus 3-vessel disease. Eight patients had left main trunk disease,
and 18 patients with non–left main trunk disease had proximal left anterior descending coronary artery (LAD)
disease. Forty-two patients showed indications of coronary revascularization (coronary artery bypass grafting
in 17 and percutaneous coronary intervention in 25). During the entire follow-up (287.6  183.2 days) of 39 pa-
tients undergoing coronary revascularization, all were alive without myocardial infarction, but 8 experienced vit-
reous hemorrhage.
Conclusions: Approximately 25% of patients with diabetic retinopathy receiving ophthalmologic care as outpa-
tients have a significant stenotic coronary artery disease. Of the total diabetic population, a large number of pa-
tients with diabetic retinopathy who show strong indications for early coronary artery bypass grafting might well
go unrecognized. (J Thorac Cardiovasc Surg 2010;139:92-7)Coronary artery disease (CAD) is the leading cause of death
in diabetic patients, accounting for 75% of deaths.1 The risk
of CAD events varies widely from patient to patient and
even within a diabetic patient as the disease progresses. Di-
abetic retinopathy (DR) is an early sign of microvascular
complication of diabetes, its severity being directly related
to the duration of the diabetes and to the amount of increase
in blood glucose concentration.2 Evidence demonstrates that
the severity of DR is associated with a graded increased
risk of myocardial infarction and death from CAD.3-11e Departments of Cardiothoracic Surgery,a Cardiology,b Ophthalmology,c En-
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The Journal of Thoracic and Cardiovascular SurgeWe reviewed the literature regarding the association be-
tween DR and CAD and hypothesized that a large number
of patients with DR and CAD who could benefit greatly
from early coronary artery bypass grafting (CABG) would
not be identified until the occurrence of a catastrophic event,
such as overt heart failure or sudden death.12 In this regard
we opened a novel clinic named the diabetic retinocoronary
clinic for the purpose of identification and treatment of oc-
cult CAD in patients with DR, and this article reports our
experience in this clinic.MATERIALS AND METHODS
Study Patients
The concept of a diabetic retinocoronary clinic was approved by the Uni-
versity of Tokyo Institutional Board for Outpatients in December 2006, and
the clinic was opened in April 2007. Patients with DR receiving ophthalmo-
logic care asoutpatients inour hospital inwhomCADhadnotpreviouslybeen
suspected were referred randomly to the clinic by ophthalmologists or endo-
crinologists. Patientswhohad type 1diabetesmellitus, requiredhemodialysis,
or bothwere excluded from this study.All patients provided informed consentry c January 2010
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CABG ¼ coronary artery bypass grafting
CAD ¼ coronary artery disease
CT ¼ computed tomography
DES ¼ drug-eluting stent
DR ¼ diabetic retinopathy
ECG ¼ electrocardiography
ETT ¼ exercise treadmill test
LAD ¼ left anterior descending coronary artery
LMT ¼ left main trunk
NPDR ¼ nonproliferative diabetic retinopathy
PCI ¼ percutaneous coronary intervention
PDR ¼ proliferative diabetic retinopathy
and were asked to participate in a screening that included a cardiovascular
history and a physical examination, risk factor assessment, resting electro-
cardiography (ECG), and an exercise treadmill test (ETT). The positivity
of the ETT was determined by using conventional criteria (1 mm of hor-
izontal or downsloping ST-segment depressions at 80 ms after the end of the
QRS complex [from the J points]). The results of the ETT were classified as
negative, positive (if ST-segment depression exceeded 2 mm), or nondiag-
nostic.13 If patients had limitations that precluded the ETT, such as limita-
tion of physical activity associated with severely impaired vision, peripheral
arterial disease, or an abnormal resting ECG result or if the results of ETT
were nondiagnostic, they were approached for exercise thallium scintigra-
phy or coronary computed tomography (CT). Patients with positive ETT re-
sults, abnormal scintigraphic results, or CT results indicating CAD were
approached for coronary angiography. A significant stenotic CAD was con-
firmed by means of coronary angiography. The findings reported in this
study were documented for all patients as of November 15, 2008.
Severity of DR
The severity in the more affected eye was used, and the patients with ret-
inopathy were grouped into 2 categories: those with nonproliferative dia-
betic retinopathy (NPDR; only microaneurysms or microaneurysms plus
1 or more the following: retinal hemorrhages, soft exudates, hard exudates,
intraretinal microvascular abnormalities, or venous beading) and those with
proliferative diabetic retinopathy (PDR; the presence of new vessels, prere-
tinal or vitreous hemorrhages, panretinal photocoagulation scarring, and
a history of vitreous surgery).2
Coronary Angiography
Angiographic analysis was performed and evaluated by experienced car-
diologists. The severity of CADwas determined based on stenosis of the left
main trunk (LMT; defined as lesions causing lumen narrowing by 50%)
and the number of vessels with 70% or greater stenosis. The proximal LAD
was defined as the vessel between the circumflex takeoff and the first major
septal or diagonal branch.
RESULTS
Between April 2007 and October 2008, 286 consecutive
patients with DRwere referred to the diabetic retinocoronary
clinic. Thirty-four patients refused to undergo diagnostic
tests, and 38 did not have a definitive diagnosis by Novem-
ber 15, 2008. The remaining 214 patients were included in
this study. Of them, 59 patients had NPDR, and 155 had
PDR.The Journal of Thoracic and COne hundred seventy-six (82.2%) patients were com-
pletely asymptomatic; 25 (11.7%) were revealed during his-
tory taking by cardiac surgeons and cardiologists to have
chest discomfort, but their symptoms were not typical of an-
gina pectoris. Furthermore, limited physical activity pre-
vented a precise evaluation of angina pectoris in 11 (5.1%)
patients with severely impaired vision and in 2 (0.9%) pa-
tientswith peripheral arterial disease.Of the study group, nor-
mal resting ECG results were seen in 159 (74.3%), Q waves
were seen in 4 (1.9%), nonspecific ST-T changes were seen
in 39 (18.2%), right bundle branch block was seen in 9
(4.2%), atrial fibrillation was seen in 2 (0.9%), and sec-
ond-degree atrioventricular block was seen in 1 (0.5%).
Of the 172 patients undergoing ETT, 50 (29.1%) had
a positive ETT result, 106 (61.7%) had a negative ETT re-
sult, and 15 (8.7%) had nondiagnostic results. The patients
who had limitations that precluded the ETT (n ¼ 42) or had
nondiagnostic results on the ETT were approached for exer-
cise thallium scintigraphic analysis or coronaryCT scanning.
Thirty-three patients underwent exercise thallium scintigra-
phy, and 8 (24.2%) had abnormal results. Twenty-four
patients underwent coronary CT, which revealed atheroscle-
rotic CAD in 7 (29.2%).
Sixty-five patients underwent coronary angiography.
Overall, of 214 study patients, 55 (25.7%) were confirmed
as having significant stenotic CAD (Figure 1). The baseline
characteristics of the patients with an angiographically con-
firmed CAD were compared with those of patients with neg-
ative results on diagnostic tests (Table 1). Patients with
angiographically confirmed CAD were older (62.2  9.8
vs 57.9  10.3 years, P ¼ .01). Twenty (46.5%) of 43 pa-
tients with Q-wave or ST-T changes on resting ECGs had
CAD, whereas 35 (20.5%) of 171 patients without these ab-
normalities had CAD (P¼ .001). The serum creatinine level,
estimated glomerular filtration rate, hemoglobin A1c level,
low-density lipoprotein level, and high-density lipoprotein
level were similar in the 2 groups. Neither the severity of
DR nor treatment with insulin was associated with angio-
graphically confirmed CAD.
Of the 55 patients with CAD, 8 (14.5%) had LMT dis-
ease, 18 (32.7%) patients without LMT disease had proxi-
mal LAD disease, and 29 patients had non-LMT,
nonproximal LAD disease (Figure 1). One-vessel disease
was seen in 15 (27.3%), 2-vessel disease was seen in 17
(30.9%), 3-vessel disease was seen in 14 (25.5%), LMT
plus 1-vessel disease was seen in 1 (1.8%), LMT plus
2-vessel disease was seen in 2 (3.6%), and LMT plus
3-vessel disease was seen in 5 (9.1%) patients. In a daily
coronary conference held within our institution, CABG
was recommended for 17 patients, percutaneous coronary
intervention (PCI) was recommended for 25 patients, and
aggressive medical therapy alone was recommended for
13 patients. For all patients with LMT disease, coronary re-
vascularization was indicated. Of 18 patients without LMTardiovascular Surgery c Volume 139, Number 1 93
FIGURE 1. Incidence of occult coronary artery disease in 214 patients with diabetic retinopathy who were referred to the diabetic retinocoronary clinic.
Fifty-five (25.7%) patients had angiographically confirmed coronary artery disease. Eight (14.5%) of them had left main trunk (LMT) disease, and 18
(32.7%) had proximal left anterior descending coronary artery (LAD) disease.
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to have indications for revascularization. Thus far, 12 have
undergone CABG, and 27 have undergone PCI. Three pa-
tients for whom CABG was recommended consented to un-
dergo only PCI. Three refused coronary revascularization by
means of either CABG or PCI. During the entire follow-up
(287.6  183.2 days), from the initial coronary revascular-
ization, all patients have remained alive without myocardial
infarction. However, vitreous hemorrhage occurred in 4
patients with PDR receiving CABG and in 4 patients with
PDR receiving PCI (Figure 2). No patients with NPDR expe-
rienced vitreous hemorrhage. The mean interval between the
initial revascularization and the occurrence of vitreous hem-
orrhage was 118 days (range, 6–387 days). Six patients expe-
rienced vitreous hemorrhage within 6 months after the initial
revascularization and 7 within 1 year after revascularization.TABLE 1. Baseline characteristics of patients with diabetic retinopathy w
Characteristic
Patients with angiographica
confirmed CAD (n ¼ 55)
Mean age (y) 62.2  9.8
Female sex, no. (%) 11 (20.0)
Height (cm) 163.0  8.2
Body weight (kg) 65.9  14.4
Body mass index 24.8  4.8
NPDR, no. (%) 17 (30.9)
PDR, no. (%) 38 (69.1)
Treatment with insulin, no. (%) 21 (38.2)
Q-wave/ST-T change, no. (%) 20 (36.4)
Hemoglobin A1c (%) 7.3  1.7
Mean serum creatinine (mg/dL) 0.94  0.52
eGFR (mL/min) 69.0  19.8
BNP (pg/mL) 43.7  79.2
Mean serum LDL (mg/dL) 107.6  30.4
Mean serum HDL (mg/dL) 55.8  26.3
Mean serum triglycerides (mg/dL) 134.2  74.6
Values are presented as means  standard deviations, where shown. CAD, Coronary artery
inopathy; eGFR, estimated glomerular filtration rate; BNP, B-type natriuretic peptide; LDL
94 The Journal of Thoracic and Cardiovascular SurgeDISCUSSION
The present study revealed that of 214 patients with DR
receiving ophthalmologic outpatient care, 55 (25.7%) had
angiographically confirmed significant stenotic CAD, and
26 (12.1%) had LMT disease, proximal LAD disease, or
both. In 42 (19.6%) patients coronary revascularization
was indicated. These findings suggest that a large number
of patients with DR and CAD could go unrecognized until
the arrival of a catastrophic event, such as overt heart failure
or sudden death.
Of the 214 study patients, 87 (40.7%) were receiving in-
sulin treatment, a proportion that seems high for patients
with type 2 diabetes. All the study patients had DR, 59 dia-
betic patients had nonproliferative retinopathy, and 155 dia-
betic patients had proliferative retinopathy. Therefore our
patients, especially those with proliferative retinopathy,ho were referred to the diabetic retinocoronary clinic*
lly Patients with negative results on
diagnostic tests (n ¼ 159) P value
57.9  10.3 .01
53 (33.3) .09
162.7  8.5 .87
66.3  13.9 .88





7.4  1.4 .56
1.0  0.82 .58
69.7  25.1 .86
30.0  38.5 .10
109.2  33.6 .77
57.7  15.9 .59
135.2  81.8 .94
disease; NPDR, nonproliferative diabetic retinopathy; PDR, proliferative diabetic ret-
, low-density lipoprotein; HDL, high-density lipoprotein.
ry c January 2010
FIGURE 2. Vitreous hemorrhage in patients with diabetic retinopathy after drug-eluting stent implantation. Twenty-one days after drug-eluting stent im-
plantation, a fundus photograph (A) revealed a considerable degree of vitreous hemorrhage in the right eye. Three months after drug-eluting stent implan-
tation, the patient’s vitreous hemorrhage shows no tendency to subside with continued dual-antiplatelet therapy (B).
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high prevalence of insulin treatment can be expected.
Most patients with DR who were referred to our diabetic
retinocoronary clinic were asymptomatic. Few studies as-
sessed the incidence of CAD in asymptomatic patients
with DRwith normal ECG results and indicated that approx-
imately 20% of these patients had CAD.14-16 In the present
study 20.5% of patients with DR without Q-wave or ST-T
changes had angiographically confirmed CAD. The results
of previous studies and our results correspond closely.
One important issue is that identification of CAD is some-
times difficult, especially in patients with sight-threatening
DR. Many patients with this condition have limited physical
activity because of impaired vision.17-19 Limited physical
activity clearly reduces the appreciation of ischemic pain
and is attributed to the difficulty of evaluation of chest
pain. In this study 11 patients had severely impaired vision,
and therefore we could not evaluate their symptoms. One pa-
tient with PDR had previously had typical angina pectoris,
but he said that his angina disappeared after vitreous hemor-
rhage. Furthermore, 4 patients in whom coronary revascular-
ization was indicated refused it because they were
completely free of angina pectoris.
In patients with DR and CAD, the main treatment effect of
coronary revascularization should be to prevent myocardial
infarction and death from CAD. Evidence indicates that
PCI does not reduce the risk of death ormyocardial infarction
in patients with stable CAD.20,21 In contrast, CABG confers
survival benefit to high-risk patients, such as those with ex-
tensive coronary disease or diabetes mellitus.22,23 In addi-
tion, our previous study demonstrated that the survival
benefit of CABG over PCI is more apparent in patients
with DR than in diabetic patients without retinopathy.24
Overall consideration suggests that CABG should be the first
choice for revascularization of patients with DR and CAD.
Previously, we demonstrated that long-term survival after
CABG is closely related to the severity of DR and that pa-
tients with advanced DR have a poor prognosis.25,26 Further-
more, we showed that patients with NPDR have a greaterThe Journal of Thoracic and Crisk of target-vessel failure (defined as a composite of car-
diac death, myocardial infarction, and target-vessel revascu-
larization) after drug-eluting stent (DES) implantation.27 In
this study the prevalence of angiographically confirmed
CAD was similar in patients with NPDR (28.8%) and in
those with PDR (24.5%). However, the association between
the severity of DR and the extent of CADwere not evaluated
in this study. Nargaz and colleagues28 demonstrated that the
diffuse nature of CAD is associated with the severity of DR.
We postulate that detecting occult CAD followed by CABG
would confer survival benefit effectively in patients with
DR, especially in the early stage.
Vitreous hemorrhage is a sight-threatening complication
in patients with DR and requires vitreous surgery in persis-
tent cases. Progression of DR involving vitreous hemorrhage
can take place spontaneously in diabetic patients after coro-
nary revascularization with either PCI or CABG, but little
about the prevalence of vitreous hemorrhage after coronary
revascularization is known.29-31 A large number of patients
with DR who are at risk of vitreous hemorrhage appear to
undergo coronary revascularization. Therefore the issue of
postrevascularization vitreous hemorrhage is an important
one for both cardiologists and cardiac surgeons. This study
revealed that vitreous hemorrhage after coronary revascular-
ization was unexpectedly high in patients with PDR. Of 24
patients with PDR undergoing coronary revascularization,
6 (25%) had vitreous hemorrhage within 6 months after
the initial revascularization. Our experience indicates that
careful postoperative eye care is required. Figure 2 presents
one case. The difficulty in treating vitreous hemorrhage after
PCI with DES implantation is that prolonged dual-antiplate-
let therapy is mandatory because of further potential risk for
stent thrombosis. Therefore the future risk of vitreous hemor-
rhage might influence the choice of revascularization strat-
egy for patients with DR, and DES implantation might not
be indicated in patients with PDR.
In 2005, the Japanese Ophthalmologists Association an-
nounced that approximately 3 million Japanese people be-
tween the ages of 50 and 69 years have DR. In the presentardiovascular Surgery c Volume 139, Number 1 95
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suspected had LMT, proximal LAD disease, or both. Theo-
retically, CABGwith an internal thoracic artery graft confers
the survival benefit effectively in patients with LMT disease,
proximal LAD disease, or both. Therefore 363,000 patients
in Japan can be expected to benefit greatly from early
CABG. On the other hand, annually, approximately 20,000
patients in Japan undergo CABG; in other words, 4000 pa-
tientswithDRundergoCABGper year. These estimates sug-
gest that a large number of patients with DR in whom the
survival chances can be improved by CABG would remain
without diagnoses until a fatal coronary event. We think
that this specialized clinic might become the new model of
an institution for identifying occult CAD in patients with
DR requiring CABG.
The present study has some caveats. First, this study did
not include diabetic patients without retinopathy. Therefore
we did not estimate the relative risk of occult CAD in pa-
tients with DR compared with that in seen diabetic patients
without retinopathy. Previous studies have demonstrated
that the incidence of occult CAD in diabetic patients without
retinopathy has ranged from 1.5% to 8.5%.14-16 In addition,
the previous studies have shown that the risk of cardiac
events in diabetic patients without retinopathy is lower
than that seen in patients with DR.3-11
Second, we used ETT as a diagnostic test for CAD screen-
ing in patients in whom ETT was not precluded. Therefore,
some patients with negative results on diagnostic tests might
have a significant stenotic CAD.
Third, in this study the survival data of patients with neg-
ative diagnostic test results were not obtained. The mean fol-
low-up duration of patients with CAD since the initial
admission to our clinic was 415 days, and no one died during
this period. Therefore, long-term follow-up might be re-
quired to evaluate the survival benefit of early CABG.
Finally, in Japan medical costs are 3200 yen for ETT,
33,000 yen for coronary CT, and 94,000 yen for exercise
thallium scintigraphy. Further study is needed regarding
cost-effective analysis of our proactive strategy.
While acknowledging these caveats, we believe that the
incidence of CAD in patients with DR seems very high,
and we believe that targeting patients with DR among the
general population of diabetic patients would be a useful
strategy for improving the life expectancy of the overall
diabetic population.References
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